ABSTRACT
BACKGROUND: Purified cytoplasm of pollen (PCP) is a non-hormonal herbal remedy used to manage vasomotor symptoms (VMS), sleep and mood disorders in menopausal women not relying on Hormone Replacement Therapy (HRT). Many studies demonstrated its efficacy and safety in post-menopause but few data are available about peri-menopause. METHODS: This is a multicenter prospective observational study on Italian symptomatic women in peri- and post-menopause referring to gynecology clinics of different areas of Italy, evaluating the effects of PCP therapy on hot flashes (HFs) and other parameters included in the Greene Climacteric Scale (GCS). RESULTS: We recruited 108 peri- and post-menopausal women (mean age 53.8±4 years), evaluating them at baseline (V0) and after 3 months of PCP treatment (V1). Basal median value of all items of GCS did not differ among all subjects. We found a significant improvement of HFs (P<0.0001) and night sweats (P<0.0001) between V0 and V1. Additionally, all items of GCS apart from loss of sensitivity to limbs (P=0.0746) significantly ameliorated after PCP therapy (P<0.05). CONCLUSIONS: According to these findings, PCP may be considered as an efficacious alternative non-hormonal treatment for the management of VMS as well as mood and sleep disturbances in both peri- and post-menopause.
Subject(s)
Hot Flashes , Postmenopause , Female , Humans , Middle Aged , Cytoplasm , Hot Flashes/drug therapy , Menopause , PollenABSTRACT
OBJECTIVE: To evaluate the response of cardiovascular risk factors to the treatment of climacteric symptoms. METHODS: In this prospective study, women reporting climacteric symptoms were randomized to 3 months of treatment with either acupuncture (nâ=â19), phytoestrogens (75âmg soy isoflavones, BID; nâ=â22), or low-dose hormone therapy (HT; 0.3âmg conjugated equine oestrogens plus 1.5âmg medroxyprogesterone acetate; nâ=â20). Greene's climacteric scale, blood pressure (BP), lipids, glucose, insulin, and homeostatic model assessment of insulin resistance were assessed before and after treatment. Observed changes were compared by analysis of variance. RESULTS: HT and acupuncture reduced Greene climacteric score to a similar extent, but the effect of phytoestrogens was significantly lower (Pâ<â0.05). With acupuncture, systolic (-7.4â±â15.3 mm Hg; Pâ<â0.05) and diastolic BP (-8.3â±â7.7mm Hg; Pâ<â0.01) decreased, and the same occurred with phytoestrogens (-8.4â±â9.0 mm Hg [Pâ<â0.01] and -6.6â±â7.9 mm Hg [Pâ<â0.01]). Neither BP systolic (1.9â±â17.5 mm Hg) nor BP diastolic (-1.4â±â9.6 mm Hg) changed during HT. Low-density lipoprotein cholesterol decreased with phytoestrogens (-9.9â±â19.6âmg/dL; Pâ<â0.05), and triglycerides increased with both HT (34.5â±â12.2âmg/dL; Pâ<â0.01) and phytoestrogens (17.41â±â24.4âmg/dL; Pâ<â0.01). A slight but significant increase in homeostatic model assessment of insulin resistance (0.14â±â0.5; Pâ<â0.05) was observed after HT. CONCLUSIONS: Treatment of climacteric symptoms with acupuncture and phytoestrogens, but not HT, is associated with a clear BP reduction, and phytoestrogens with potentially positive alterations in low-density lipoprotein cholesterol level. TRIAL REGISTRATION: EudractCT Number 2008-006053-41. : Video Summary:http://links.lww.com/MENO/A637.
Subject(s)
Acupuncture Therapy , Cardiovascular Diseases , Climacteric , Isoflavones , Animals , Blood Pressure , Cardiovascular Diseases/prevention & control , Female , Heart Disease Risk Factors , Horses , Humans , Phytoestrogens , Prospective Studies , Risk FactorsABSTRACT
OBJECTIVE: To evaluate whether climacteric symptoms are related to pelvic organ prolapse (POP) in postmenopausal women. STUDY DESIGN: A cross-sectional investigation was performed on 1382 postmenopausal women attending an outpatient service for menopause at a university hospital. MAIN OUTCOME MEASURES: Data regarding climacteric symptoms, as captured by the Greene Climacteric Scale, and objective POP were retrieved from an electronic database. Additional data retrieved were age, anthropometric measures, personal and reproductive history, use of medication or drugs, coffee, smoking, state of anxiety (STAI scale score) and depression (Zung scale score). RESULTS: The score of Greene Climacteric Scale was higher (p=0.02) in women with (n=538) than in those without (n=844) POP (29.6±13.6 vs. 27.8±13.; p=0.02). In multiple logistic regression models, the score was independently related to POP as a whole (OR 1.012; 95%CI 1.003,1.022; p=0.009), and to bladder prolapse (OR 1.011; 95%CI 1.007,1.07; p=0.02) or to uterus prolapse (OR 1.003; 95%CI 0.99,1.016; p=0.63) or rectum prolapse (rectocele) (OR 1.004; 95%CI 0.988,1.02; p=0.62). CONCLUSIONS: In postmenopausal women, a higher burden of climacteric symptoms, is associated with POP. Underlying mechanisms were not assessed and deserve further investigation.